Back to the Future for Dermatophyte Genomics
Zeyana S. Rivera, Liliana Losada, and William C. Nierman
J. Craig Venter Institute, Rockville, Maryland, USA
major cause of athlete’s foot is Trichophyton rubrum, a pathogen of human skin. A recent paper in this journal reported the se-
quencing and analysis of five additional genome sequences, including that of Trichophyton rubrum. These five join the existing
gillusgenomicssincetheinitialpublicationofthefirstthree Aspergillus genomesequencesin2005,aneventthatstimulatedim-
portantstudiesofthepathogenic Aspergillus species.Fromthese7yearsof Aspergillus history,weoffersomespeculationonthe
genome sequencing and analysis of five additional dermato-
mentary, we will situate this report in the context of current der-
on the advances made in Aspergillus genomics after the first three
Aspergillus genomes were sequenced in 2005 (2–4).
Dermatophytes are a uniquely pathogenic group of fungi that
cause most common fungal infections globally (5). Dermato-
dermophyton, and Microsporum. In the United States alone, mil-
lions of individuals seek treatment for dermatophyte infections
annually, translating into an economic burden estimated at
$400 million per year (6). Moreover, large-scale epidemics have
been reported in American troops in conflicts in Europe and an
urban childcare center outbreak (7, 8). The knowledge surround-
ing the mode by which these pathogens cause disease is insuffi-
cient, perhaps due to lack of research utilizing modern molecular
tools. Due to this deficiency, the development of effective thera-
dermatophyte genomes and their pathogenicity (9).
As noted, seven whole-genome sequences of dermatophyte
species have now been generated (see the Broad Institute’s Der-
matophyte Comparative Database at http://www.broadinstitute.org
.html): the nuclear genome and mitochondrial sequences of Mi-
crosporum canis, Microsporum gypseum, Trichophyton equinum,
Trichophyton rubrum, and Trichophyton tonsurans (1), as well as
the availability of Arthroderma benhamiae and Trichophyton ver-
nez et al. (1) report that the sequenced dermatophytes are enriched
contribute to their ability to cause disease, an observation that mir-
involved in signaling necessary for adapting to the skin niche; (iii)
secondary metabolites, compounds that act as toxins, immune sys-
tem modulators, or signals in the interactions between fungus and
recent paper by Martinez et al. in this journal reported the
mune response to the fungi. Overall, these genome sequence identi-
fications are important for revealing genome components that have
the potential to further our understanding of the pathogenicity of
dermatophytes. The availability of these sequence and analysis data
The observations about the dermatophyte genomes are remi-
niscent of the observations made on the first three Aspergillus ge-
nomes that were sequenced and analyzed. This is not surprising
given that all dermatophytes and Aspergilli belong to the same
phylum, Ascomycota. Characterization and analysis of many
virulence-associated traits in Aspergillus species (1) may be useful
in the search for such traits in dermatophyte genomes. Addition-
ally, Aspergillus pathogens have been the subject of medically im-
and secreted enzymes involved in secondary metabolite produc-
tion. The genome sequences of Aspergillus fumigatus, Aspergil-
Nature papers in 2005 (2–4). Shortly after that publication event,
patients, an ability that positions them as the more important
saprophytes whose niche is decaying plant material. A. oryzae,
ancestral A. flavus, has experienced centuries of human cultiva-
and other Japanese foods. At the time of the genome sequence
Published 30 October 2012
Citation Rivera ZS, Losada L, Nierman WC. 2012. Back to the future for dermatophyte
genomics. mBio 3(6):e00381-12. doi:10.1128/mBio.00381-12.
Copyright © 2012 Rivera et al. This is an open-access article distributed under the terms
of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported License,
which permits unrestricted noncommercial use, distribution, and reproduction in any
medium, provided the original author and source are credited.
Address correspondence to William C. Nierman, email@example.com.
November/December 2012 Volume 3 Issue 6 e00381-12
publications, all but A. nidulans were presumed to be asexual. As
was the case for dermatophytes, the genome analysis of these
aspergilli revealed several striking features, including a surprising
abundance of secondary metabolite biosynthetic gene clusters, a
full set of sexual cycle genes even in the presumed asexual strains,
and an abundance of secreted degradative enzymes. The Aspergil-
lus genomes inspired a burst of studies that leveraged these ge-
nome sequences, as overviewed in Fig. 1 (12–20). Subsequent
post-genome sequence studies have revealed the identity of nu-
merous products of the secondary-metabolite biosynthetic clus-
ters and the roles of some of them in A. fumigatus and A. flavus
these organisms that are now under way; and have supported
studies of the roles of many of the secreted proteases and other
degradative enzymes in virulence. In addition, multiple strains of
A. fumigatus and A. flavus have been sequenced, with the total of
A. fumigatus sequences completed or under way approaching 100
Sexual reproduction has been suggested as a means to revamp
the virulence of fungi via meiotic recombination, which increases
may be associated with antifungal resistance or the rate of patho-
genicity of dermatophytes (21). Like the story of sex in A. fumiga-
have been demonstrated to possess sexual cycles as well (22).
Based on these studies, prediction of unexposed sexual cycles can
be assumed from the dermatophytes containing functional sex
genes. Recently, identification of the mating type locus (MAT) of
and T. tonsurans) with comparable virulence were reported using
bioinformatic tools (23). Furthermore, successful mating of T.
benefits of sex, including cross-species sexual recombination and
expansion (24). In the Aspergillus species, the APN2 and SLA2
genes, encoding a DNA lyase and cytoskeleton protein, flank the
phytes allows further studies in the pathogenesis to be explored.
The role of LysM proteins was noted for protecting dermato-
teins in avoiding detection by the host immune system is sup-
ported by the observation that during dermatophyte infection,
defective or absent cell-mediated immunity predisposes the host
to chronic or recurrent dermatophyte infection (26). Previously,
expression of hydrophobin has been demonstrated to inhibit im-
mune recognition in A. fumigatus (27). Dermatophytes A. benha-
miae and T. verrucosum, both shown to activate human inflam-
matory infections, also display moderate expression of a surface
Discovery of the abundance of secondary-metabolite biosyn-
thetic clusters in the Aspergillus genomes has led to the identifica-
of them in virulence. A similar abundance of these clusters has
For example, melanin, which is an important virulence determi-
canis, M. gypseum, T. equinum, T. rubrum, and T. tonsurans) in
vitro and during infection, suggesting a similar role in Aspergillus
and dermatophyte pathogenesis (29). Moreover, T. rubrum pro-
duces xanthomegnin, a toxin produced by Aspergillus in culture
and in the human host (30). Transcriptome analysis revealed dif-
ferential expression of secondary-metabolite genes during der-
matophyte and Aspergillus infections, underscoring their impor-
tance in the colonization of tissues and potentially in the
manipulation of the host inflammatory response (30). Future
studies will undoubtedly leverage the genome sequences of these
clusters in dermatophytes to identify their secondary-metabolite
products and their potential specific roles in virulence.
Given the recent major progress in the development of broad-
terized genes (33, 34), full genome sequences will fulfill a critical
urgency in the need to develop molecular genetic techniques to
study these pathogens. Molecular studies of dermatophyte
genomics and pathogenicity have been undertaken in spite of the
limited number of sequenced genomes. For example, Vermout
and colleagues used RNA silencing as a potential functional
genomics tool in M. canis to identify two proteases, SUB3 and
FIG 1 Aspergillus genomics timeline. The timeline highlights some of the numerous critical studies since the publication of the first three Aspergillus genome
sequences in 2005. The cited papers should be taken as representative, as no rigorous prioritization was imposed in selecting papers to highlight in the timeline.
mbio.asm.orgNovember/December 2012 Volume 3 Issue 6 e00381-12
DPPIV, coding for subtilisin and dipeptidyl peptidase, respec-
tively (35). Previous studies have also demonstrated the associa-
tion of increased keratinase with increased disease symptoms in
canis (10, 37, 38), but these have been limited in number and
coupled to genome sequences, these and other “omics” methods,
such as metabolomics, glycomics, and lipidomics, will be more
characterization of dermatophyte pathogenesis.
It is clear that the availability of additional dermatophyte ge-
nomes will accelerate and enhance molecular studies of these
pathogenic fungi. It is therefore most appropriate to celebrate the
publication of these new dermatophyte genomes and to note this
event as a consequential milestone in the efforts to manage the
terrible diseases caused by this group of fungi. The aspergilli and
the dermatophytes are closely related, and the new dermatophyte
phytes and aspergilli diseases—such as invasiveness, fatality, and
organ involvement—have resulted in research communities with
disproportionate funding support that favored more rapid ad-
vancement in the aspergilli than in dermatophytes. Another im-
portant factor that favored the aspergilli was the strength of A.
developed around this model prior to the genome sequence pub-
and will continue to be, synergistic, with each community taking
lessons from the other. We project that the rate of progress in
dermatophyte genomic research will accelerate now in much the
same way Aspergillus research accelerated following the publica-
to all the exciting and significant findings yet to come.
1. Martinez DA, et al. 2012. Comparative genome analysis of Trichophyton
rubrum and related dermatophytes reveals candidate genes involved in
infection. mBio 3(5):e00259–12.
2. Nierman WC, et al. 2005. Genomic sequence of the pathogenic and aller-
3. Machida M, et al. 2005. Genome sequencing and analysis of Aspergillus
oryzae. Nature 438:1157–1161.
4. Galagan JE, et al. 2005. Sequencing of Aspergillus nidulans and compar-
ative analysis with A. fumigatus and A. oryzae. Nature 438:1105–1115.
6. Smith ES, Fleischer AB, Jr, Feldman SR. 1998. Nondermatologists are
more likely than dermatologists to prescribe antifungal/corticosteroid
products: an analysis of office visits for cutaneous fungal infections,
1990–1994. J. Am. Acad. Dermatol. 39:43–47.
7. Burzykowski T, et al. 2003. High prevalence of foot diseases in Europe:
results of the Achilles Project. Mycoses 46:496–505.
8. Abdel-Rahman SM, Simon S, Wright KJ, Ndjountche L, Gaedigk A.
2006. Tracking Trichophyton tonsurans through a large urban child care
ular strain typing. Pediatrics 118:2365–2373.
9. Grumbt M, Monod M, Staib P. 2011. Genetic advances in dermato-
phytes. FEMS Microbiol. Lett. 320:79–86.
10. Burmester A, et al. 2011. Comparative and functional genomics provide
insights into the pathogenicity of dermatophytic fungi. Genome Biol. 12:
11. Payne G, et al. 2006. Whole genome comparison of Aspergillus flavus and
A. oryzae. Med. Mycol. 44:9–12.
12. Abe K, Gomi K, Hasegawa F, Machida M. 2006. Impact of Aspergillus
13. Wortman J, et al. 2006. Whole genome comparison of the A. fumigatus
family. Med. Mycol. 44:3–7.
Aspergillus fumigatus by LaeA. PLoS Pathog. 3:e50.
fungus Aspergillus fumigatus. PLoS Genet. 4:e1000046.
17. Balajee SA, et al. 2009. Sequence-Based Identification of Aspergillus,
Fusarium, and Mucorales Species in the Clinical Mycology Laboratory:
Where Are We and Where Should We Go from Here?. J. Clin. Microbiol.
18. Khaldi N, et al. 2010. SMURF: genomic mapping of fungal secondary
metabolite clusters. Fungal Genet. Biol. 47:736–741.
Aspergillus. Mol. Ecol. 21:1305–1306.
20. Sugui JA, et al. 2011. Identification and characterization of an Aspergillus
fumigatus “supermater” pair. mBio 2(6):e00234–11.
21. Hsueh YP, Heitman J. 2008. Orchestration of sexual reproduction and
virulence by the fungal mating-type locus. Curr. Opin. Microbiol. 11:
22. Heitman J. 2010. Evolution of eukaryotic microbial pathogens via covert
sexual reproduction. Cell Host Microbe 8:86–99.
23. Li W, Metin B, White TC, Heitman J. 2010. Organization and evolu-
tionary trajectory of the mating type (MAT) locus in dermatophyte and
dimorphic fungal pathogens. Eukaryot. Cell 9:46–58.
24. Anzawa K, Kawasaki M, Mochizuki T, Ishizaki H. 2010. Successful
mating of Trichophyton rubrum with Arthroderma simii. Med. Mycol. 48:
25. Fraser JA, et al. 2007. Evolution of the mating type locus: insights gained
26. Almeida SR. 2008. Immunology of dermatophytosis. Mycopathologia
27. Aimanianda V, et al. 2009. Surface hydrophobin prevents immune rec-
ognition of airborne fungal spores. Nature 460:1117–1121.
28. Youngchim S, Morris-Jones R, Hay RJ, Hamilton AJ. 2004. Production
of melanin by Aspergillus fumigatus. J. Med. Microbiol. 53:175–181.
29. Youngchim S, Pornsuwan S, Nosanchuk JD, Dankai W, Vanittanakom
N. 2011. Melanogenesis in dermatophyte species in vitro and during in-
fection. Microbiology 157:2348–2356.
30. Staib P, et al. 2010. Differential gene expression in the pathogenic der-
matophyte Arthroderma benhamiae in vitro versus during infection. Mi-
31. Giddey K, et al. 2007. Comprehensive analysis of proteins secreted by
Trichophyton rubrum and Trichophyton violaceum under in vitro condi-
tions. J. Proteome Res. 6:3081–3092.
32. Liu T, et al. 2007. The use of global transcriptional analysis to reveal the
biological and cellular events involved in distinct development phases of
Trichophyton rubrum conidial germination. BMC Genomics 8:100.
33. Yamada T, Makimura K, Abe S. 2006. Isolation, characterization, and
disruption of dnr1, the AreA/Nit-2-like nitrogen regulatory gene of the
zoophilic dermatophyte, Microsporum canis. Med. Mycol. 44:243–252.
34. Fachin AL, Ferreira-Nozawa MS, Maccheroni W, Jr, Martinez-Rossi
NM. 2006. Role of the ABC transporter TruMDR2 in terbinafine,
4-nitroquinoline N-oxide and ethidium bromide susceptibility in Tricho-
phyton rubrum. J. Med. Microbiol. 55:1093–1099.
35. Vermout S, et al. 2007. RNA silencing in the dermatophyte Microsporum
canis. FEMS Microbiol. Lett. 275:38–45.
36. Viani FC, Dos Santos JI, Paula CR, Larson CE, Gambale W. 2001.
Production of extracellular enzymes by Microsporum canis and their role
in its virulence. Med. Mycol. 39:463–468.
37. Sriranganadane D, et al. 2011. Identification of novel secreted proteases
during extracellular proteolysis by dermatophytes at acidic pH. Proteom-
38. Leng W, et al. 2008. Proteomic profile of dormant Trichophyton rubrum
conidia. BMC Genomics 9:303.
November/December 2012 Volume 3 Issue 6 e00381-12